Physician profile
Thomas George
NPI 1457334583
$3,886.53
in general payments reported to CMS, 2019-2025
12 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2021: $133 · 2022: $410 · 2023: $794 · 2024: $1,189 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Travel and Lodging: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.32 |
| Travel and Lodging | $113.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,115.00 | 2019 | |
| Integra Lifesciences Corporation | $1,016.03 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $360.41 | 2021-2024 | Stravix |
| Stryker Corporation | $285.07 | 2023-2024 | Prostep, Fixos |
| Polynovo North America LLC | $283.55 | 2024-2025 | Novosorb Btm |
| Orthofix Medical, INC. | $207.75 | 2024 | Truelok |
| Anika Therapeutics, INC. | $157.84 | 2024 | Integrity, Tactoset |
| Paragon 28, INC. | $121.07 | 2023 | Portfolio |
| Paratek Pharmaceuticals, INC. | $114.29 | 2023 | Nuzyra |
| Depuy Synthes Sales INC. | $91.68 | 2022 | |
| Biocomposites INC | $69.73 | 2025 | Stimulan |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.